Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;21(7):913-914.
doi: 10.1016/S1473-3099(21)00202-4. Epub 2021 Apr 13.

SARS-CoV-2 incidence and vaccine escape

Robin N Thompson  1 , Edward M Hill  2 , Julia R Gog  3
Affiliations
Comment

SARS-CoV-2 incidence and vaccine escape

Robin N Thompson et al. Lancet Infect Dis. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors report being members of the Joint Universities Pandemic and Epidemiological Research consortium (JUNIPER) and participants of the UK Government's Scientific Pandemic Influenza Group on Modelling, Operational subgroup (SPI-M). EMH reports a grant from the UK Medical Research Council during the conduct of the study. JRG reports a grant from UK Research and Innovation to the JUNIPER modelling consortium.

Figures

Figure
Figure
Risk that at least one vaccine escape variant arises in a time period of length t, for different daily numbers of cases The per-infection probability of vaccine escape is p = 2 × 10−7 (for details, see the appendix).
See this image and copyright information in PMC

Comment on

References

    1. The Lancet Infectious Diseases An exceptional vaccination policy in exceptional circumstances. Lancet Infect Dis. 2021;21:149. - PMC - PubMed
    1. Cobey S, Larremore DB, Grad YH, Lipsitch M. Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination. 2021. https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37366988 - PMC - PubMed
    1. Saad-Roy CM, Morris SE, Metcalf CJE, et al. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science. 2021 doi: 10.1126/science.abg8663. published online March 9. - DOI - PMC - PubMed
    1. Gog JR, Hill EM, Danon L, Thompson RN. Vaccine escape in heterogeneous populations: insights for SARS-CoV-2 from a simple model. medRxiv. 2021 doi: 10.1101/2021.03.14.21253544. published online March 17. (preprint). - DOI - PMC - PubMed
    1. Bieniasz PD. The case against delaying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine boosting doses. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab070. published online Jan 27. - DOI - PMC - PubMed